Zotiraciclib (TG02) Plus Dose-Dense or Metronomic Temozolomide Followed by Randomized Phase II Trial of Zotiraciclib (TG02) Plus Temozolomide Versus Temozolomide Alone in Adults With Recurrent Anaplastic Astrocytoma and Glioblastoma
Phase 1/2 Terminated
53 enrolled 22 charts
Re-Administration of C134 in Patients With Recurrent GBM (C134-HSV-1)
Phase 1 Terminated
1 enrolled
Study of Efficacy and Safety of Ribociclib (LEE011) in Combination With Topotecan and Temozolomide (TOTEM) in Pediatric Patients With Relapsed or Refractory Neuroblastoma and Other Solid Tumors
Phase 1 Terminated
12 enrolled
REGN2810 in Pediatric Patients With Relapsed, Refractory Solid, or Central Nervous System (CNS) Tumors and Safety and Efficacy of REGN2810 in Combination With Radiotherapy in Pediatric Patients With Newly Diagnosed or Recurrent Glioma
Phase 1/2 Terminated
57 enrolled 31 charts
CNS Penetration, PK and PD of Preoperative CC-90010 in Progressive/Recurrent Diffuse Astrocytoma, Anaplastic Astrocytoma and Glioblastoma
Phase 1 Terminated
20 enrolled
DIPG
Phase 1 Terminated
4 enrolled
Safety, Tolerability, Efficacy and Pharmacokinetics of Copanlisib in Pediatric Patients
Phase 1/2 Terminated
31 enrolled 17 charts
PIVOT IO 020
Phase 1/2 Terminated
15 enrolled 14 charts
A Phase 1 / 2 Dose Escalation Study of Locally-Administered OncoGelâ„¢ in Subjects With Recurrent Glioma
Phase 1/2 Terminated
4 enrolled 5 charts
SPOC2013-001
Phase 1 Terminated
4 enrolled
Phase 1/2 Study of USL311 +/- Lomustine in Advanced Solid Tumors or Relapsed/Recurrent Glioblastoma Multiforme (GBM)
Phase 1/2 Terminated
26 enrolled 20 charts
Study of Fixed vs. Flexible Filgrastim to Accelerate Bone Marrow Recovery After Chemotherapy in Children With Cancer
Phase 3 Terminated
23 enrolled 9 charts
Toca5
Phase 2/3 Terminated
403 enrolled
Response Monitoring Trial in Patients With Suspected Recurrence of Glioblastoma
Phase 1 Terminated
31 enrolled
Genetic Susceptibility and Risk of Second Cancers in Patients Who Have Undergone Stem Cell Transplant for Cancer
Terminated
1,000 enrolled
Antineoplaston Therapy in Treating Patients With Low-Grade Astrocytoma
Phase 2 Terminated
7 enrolled 6 charts
CaBaMet
Phase 2 Terminated
8 enrolled
Antithymocyte Globulin, Clofarabine, and Rituximab in Treating Patients After an Unsuccessful Stem Cell Transplant
Phase 2 Terminated
12 enrolled 12 charts
Randomized Phase 2 Study to Investigate Efficacy of ALECSAT in Patients With GBM Measured Compared to Avastin/Irinotecan
Phase 2 Terminated
25 enrolled
Post-approval Study of NovoTTF-100A in Recurrent GBM Patients
Phase 4 Terminated
13 enrolled
Memantine for Recurrent Glioblastoma
Phase 2 Terminated
4 enrolled 3 charts
HGG-CilMetro
Phase 2 Terminated
28 enrolled
Gamma-Secretase Inhibitor RO4929097 in Treating Young Patients With Relapsed or Refractory Solid Tumors, CNS Tumors, Lymphoma, or T-Cell Leukemia
Phase 1 Terminated
129 enrolled
Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid Tumors
Phase 1 Terminated
19 enrolled